Changing of the Cancer Screening
The Bluestain® project resulted from the need to materialize a research project with a business vocation. Its purpose is to promote point of care diagnostic solutions and provide simplified diagnostic processes that can reach the entire population, with high quality standards guaranteed by scientific validation by experts in the field.
A breakthrough in cytological staining
- Fast
- Simple
- Sustainable
- Economical
About us
BlueStain Global Ltd is a company established in London, UK between CESPU Diagnóstico (Portugal) and IKAR Arabia (United Kingdom).
About CESPU Diagnóstico
CESPU Diagnóstico, is part of Portuguese CESPU Group, which is a Higher Education Institution that has been training highly qualified health professionals for over 40 years.
CESPU Diagnóstico, is a company created as a startup within the scope of the innovation developed in the IUCS research centers (initially called Targetalent) for the transfer of innovation. It resulted from a scientific research project, through which a new methodology for cytological diagnosis was developed, based on cytology and applied to telepathology.
The mission of CESPU Diagnóstico is to develop, implement, manufacture, and make available to the market medical devices in the diagnostic area based on cytological and molecular studies. The vision is to be a reference company, in the area of research, providing products and services that meet the requirements of manufacturing, clinical and laboratory diagnosis. Each partnership/business relationship is assured by commitment, rigor and quality, which are an integral part of the company.
About IKAR Arabia
IKAR Arabia Investment Group is one of the vertical operating groups, belonging to IKAR Holdings, which is a multi-tiered group headquartered in London, encompassing more than 40 companies – spanning across 14 different sectors and geographical regions.
IKAR Holdings is a distinguished ecosystem of entrepreneurs, innovators, and investors from around the world that spans across a wide variety of industries and sectors. Our mission revolves around the commitment to empower growing business and emerging leaders globally.
IKAR Holdings is a multi-tiered group headquartered in London, encompassing more than 40 companies – spanning across diverse sectors and geographical regions. Its structure is reinforced by a network of external global partnerships and steered by a leadership team composed of accomplished business executives with established track records of success, united with the insights and expertise of senior figures from the political and public sectors.
About BlueStain
BlueStain is a simple cancer diagnostic test that meets high quality standards and allows to stain a variety of cytological samples simply and quickly, with clear definition of cell structures, either in conventional or thinprep smears, fixed in alcohol or dried at room temperature.
BlueStain®️ is a reliable clinical tool for the evaluation of the suitability, screening, and preliminary diagnosis of a variety of cytology specimens.
Its application optimizes resource usage and puts the device at the disposal of all forms of screenable cancer through cytology.
It covers applications for Thyroid , Cervix, Oral, Anal samples and serous fluid.
How BlueStain works
An in vitro diagnostic medical device that meets high quality standards and allows you to stain a variety of cytological samples simply and quickly, with clear definition of cell structures, either in conventional or thinprep smears, fixed in alcohol or dried at room temperature.
This medical device is a reliable clinical tool for the evaluation of the suitability, screening, and preliminary diagnosis of a variety of cytology specimens. Its application optimizes resource usage and puts the device at the disposal of all forms of screenable cancer through cytology.
The BlueStain® method consists of cytoplasmic and nuclear staining, which can be performed in just 2 minutes, allowing:
– Definition of nuclear details, providing a perfect analysis of inflammatory and neoplastic changes.
– Cytoplasmic transparency, of particular importance because of the different cell thicknesses and frequent cell overlap in the sample.
Highlight Publications
– Ferreira, F., Alves, D., Oliveira, T., Coelho, S., Oliveira, I., & de Melo Alves, P. (2023). Evaluation of saliva as an alternative to standard collection for detection of SARS-CoV-2. Scientific Letters, 1(1), 3. https://doi.org/10.48797/sl.2023.0
– De Melo Alves, P., Ferreira, F., Oliveira, T., Alves, D., Canberk, S., & Schmitt, F. C. (2023). A New Cytology Staining Method: A Fast Approach for Rapid On-Site Evaluation on Thyroid Fine-Needle Aspiration Cytology. Acta Cytologica, 67(3), 289–294. https://doi.org/10.1159/000527347
Awards
How BlueStain works
Leadership
Board of Directors
Prof. Fernando Ferreira
Chairman of the Board – CEO, CESPU Diagnóstico
Mario Diel
Independent Member – Chairman, IKAR Arabia Investment Group
Sertan Ayçiçek
Independent Member – Deputy Chairman, IKAR Arabia Investment Group
Kerem Etkin
Member – Director, BlueStain Global
Executive Board
Prof. Manuel Freire-Garabal y Núñez
Chief Executive Officer, BlueStain Global
Semih Ayçiçek
Chief Financial Officer, BlueStain Global
Prof. Paula Melo
Chief Operating Officer, BlueStain Global
